Subscribe

login / sign up

close and back to page

Latest News

Latest News

VIDEO: Benita Byrd Talks About Growing at Abbott

Byrd, director of global operations, environmental health and safety for Abbott's vascular business, talks about her career journey.

Benita Byrd is the director of global operations, environmental health and safety for Abbott's (No. 14 on the DiversityInc Top 50 Companies list) vascular business.

Byrd first joined us as a part of the professional development program. In the following video, she talks about her journey at Abbott.


 

 

Abbott: Heart Tech Gives Second Chance at Life

Advances in heart technology are helping people lead longer lives without a transplant.

Originally Published by Abbott.

In a strange way, getting robbed at gunpoint saved Tyrone Morris's life.

The scare eventually led to the discovery that Morris was living with congestive heart failure. Morris was just 38 years old, and his doctors were telling him that he had six months to live.

But thanks to three innovative pieces of heart technology from Abbott, Morris has been given a second — and even a third — chance at life.

This is his story.

A shocking diagnosis

On Sept. 14, 2011, Morris was working in the Milwaukee retail store he managed when two men entered the store around closing time. One intruder locked the doors; the other put a 9 mm pistol to Morris's head and demanded the money in the safe. His heart started racing — and didn't stop, even after the safe opened and the robbers left.

"I felt my heart drop in that moment," Morris said. "My heart just stopped working."

After that day, Morris says, his heart just felt worse and worse. About a year after the robbery, Morris was playing basketball when he noticed that he was having trouble getting up and down the court. This wasn't like him: He played college basketball at Crowley's Ridge College in Arkansas, and grew up working on a farm in rural Missouri.

Finally, Morris went to see his family doctor.

"She told me, 'Tyrone, we're taking you to the hospital,'" he said.

Morris refused to go. He went home. But his doctor called him repeatedly and urged him into going to the emergency room. Once Morris arrived at the ER, doctors almost immediately wheeled him back for surgery.

The diagnosis: congestive heart failure. Morris needed a pacemaker. He was just 38 years old — far too young for such a severe diagnosis, he thought.

"When I was first diagnosed, I didn't believe it," he said. "I never believed it until I got really sick with it."

Life-saving heart technology

Morris didn't have time to be sick.

He had a family to raise.

He had a restaurant, Big Country's Barbecue, to run.

He had his weekly bowling league — the sport he picked up when his heart problems prevented him from playing basketball.

Morris took his medications and visited his doctor regularly. But he was still leading a busy life, sometimes spending 14-hour days at his restaurant. About a year after his pacemaker was implanted, doctors discovered that his heart was retaining fluid — a dangerous complication for someone with congestive heart failure.

Morris's doctors recommended the CardioMEMS™ HF System. The heart failure monitoring system allows Morris's doctors to keep a close watch on him, wherever he is. Once a day, Morris lies on a pillow that measures his heart function, and the system wirelessly transmits those measurements to his care team.

"The CardioMEMS is excellent," Morris said. "It lets them know if my fluid is too high. It was a simple procedure."

But even with the pacemaker and CardioMEMS, Morris's heart kept getting worse. By 2014, Morris was unable to climb his stairs at home to bring in groceries. His heart was running out of time, his doctors said. He was going to need a new one.

When he was cleared for the transplant list, his doctors implanted Abbott's HeartMate 3™ left ventricular assist device (LVAD) — more commonly known as a heart pump — as a bridge-to-transplant therapy. The HeartMate 3 LVAD takes over the pumping function of your heart and can prolong the lives of those waiting for a transplant. It is also an option for those not eligible for a new heart.

But Morris didn't want a heart pump that would interfere with his life. So he asked for one small concession. Normally, the LVAD's wires come out of the right side of the body.

"I told my doctors I need them to come out my left side so I can continue to bowl," Morris said. "They made it work for me, and a week after I recovered and started bowling again, I bowled a perfect 300 game."

A stronger heart, a new outlook

With three heart technology devices keeping him alive, Morris is thankful for every day.

"I'm very thankful, very grateful," he said. "The changes that I've made, the technology, it gave me life, it gave me breath. It made me relive my life."

Morris regularly talks to congestive heart failure patients at the same hospital where he received treatment. He warns people not to ignore their diagnoses. He spent too much time denying his as his heart weakened, he says, and he encourages others not to make the same mistake.

"I tell everybody, don't take it for granted," he said. "Don't throw your diagnosis in the trash. It is real. It is serious. And if you catch it early, you can get the proper help."

He's often asked about how he's recovering from HeartMate 3 surgery, which can take months. Morris says that everything is what you make of it, and that it helps to have a strong support system — and a sense of humor.

"I crack jokes," he said. "I have fun, even when I'm down. I always tell myself every day is going to be a good day, especially having my wife wait on me hand and foot during recovery. We cracked jokes and made the best out of it."

The Food and Drug Administration (FDA) recently approved the HeartMate 3 as a destination therapy, which gives hope to people who are waiting for a transplant, such as Morris, as well as people who aren't eligible for one.

"I want a heart transplant, but if I had to live my life with the pump, I'd still be happy," he said. "I'd still do what I'm doing."

Thanks to his three Abbott heart devices, Morris is able to run his restaurant — where he's committed to serving all his food with no added salt. He's still shooting jumpers and bowling, still knocking down about 226 pins each game.

"I'm living the dream," he said. "Don't wake me up, either. Let me live."

Abbott to Acquire Cephea Valve Technologies, Inc.

Acquisition to further bolster Abbott's leading position in therapies for mitral valve disease, the most common type of heart valve ailment.

Abbott has announced that it has exercised its option to purchase Cephea Valve Technologies, Inc., a privately held medical device company developing a less-invasive heart valve replacement technology for people with mitral valve disease. Financial terms were not disclosed. Abbott provided capital and secured an option to purchase Cephea in 2015.

Read More Show Less

Abbott: A Healthy Outlook for the New Year

Abbott CFO highlights promising product pipeline and sustainable growth at key investor conference.

Originally Published by Abbott.

Each year brings resolutions; For Abbott, a new year means it is ready to keep delivering on its promises for better health through its life-changing technologies and translating that success into another year of outstanding performance.

Read More Show Less